Beyond Air® Receives Grant for Up to $2.17 million from the Cystic Fibrosis Foundation to Advance the Clinical Development of Inhaled Nitric Oxide to Treat Nontuberculous Mycobacteria Pulmonary DiseaseGlobeNewsWire • 02/16/21
Beyond Air's (XAIR) CEO Steve Lisi on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 02/10/21
Beyond Air® Reports Financial Results for Third Quarter of Fiscal Year 2021 and Provides Business UpdateGlobeNewsWire • 02/09/21
Beyond Air® Schedules Third Fiscal Quarter 2021 Financial Results Conference Call and WebcastGlobeNewsWire • 01/15/21
Beyond Air Offers Compelling Value Heading Into Its First Potential Product ApprovalSeeking Alpha • 12/19/20
Beyond Air® to Participate in the 32nd Annual Piper Sandler Healthcare Conference from December 1-3, 2020GlobeNewsWire • 11/19/20
Beyond Air, Inc. (XAIR) CEO Steve Lisi on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/12/20
Beyond Air® Submits Premarket Approval Application to FDA for LungFit™ PH to Treat Persistent Pulmonary Hypertension of the NewbornGlobeNewsWire • 11/11/20
Beyond Air® Schedules Second Fiscal Quarter 2021 Financial Results Conference Call and WebcastGlobeNewsWire • 10/23/20
Beyond Air® Approved to Initiate Clinical Study at 150 ppm Nitric Oxide with LungFit™ for the Treatment of Acute Viral Pneumonia Including COVID-19GlobeNewsWire • 10/21/20
Beyond Air® Presents In Vivo Solid Tumor Data Confirming In Situ Cancer Vaccination with a Single Injection of Gaseous Nitric Oxide at the AACR Conference on Tumor Immunology and ImmunotherapyGlobeNewsWire • 10/19/20
Beyond Air® Presents Data Showing Anti-Coronavirus Activity of Nitric Oxide at the CHEST Annual Meeting 2020GlobeNewsWire • 10/19/20
Beyond Air® Presents Pilot Bronchiolitis Data at the CHEST Annual Meeting 2020GlobeNewsWire • 10/19/20
Beyond Air® Presents Positive New Preclinical Data for the Use of a Single Injection of Gaseous Nitric Oxide as a Novel In situ Cancer VaccinationGlobeNewsWire • 10/16/20
Beyond Air to Present at the Oppenheimer & Co. Fall Healthcare Life Sciences and MedTech SummitGlobeNewsWire • 09/11/20
Beyond Air® to Present Posters on CoronaVirus and Bronchiolitis at the CHEST 2020 Annual MeetingGlobeNewsWire • 09/09/20
Beyond Air® to Present New Nitric Oxide Data in an e-Poster Presentation at the North America Conference on Lung Cancer 2020 (NACLC 2020)GlobeNewsWire • 08/27/20
Beyond Air Publishes New Data on Nitric Oxide to Treat M. Abscessus in the Peer-Reviewed Journal Access MicrobiologyGlobeNewsWire • 08/10/20
Beyond Air, Inc. (XAIR) CEO Steve Lisi on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/08/20
Will AIT Therapeutics, Inc. (XAIR) Report Negative Earnings Next Week?Zacks Investment Research • 07/30/20
Beyond Air® to Announce Fiscal First Quarter 2021 Financial Results on Thursday, August 6thGlobeNewsWire • 07/23/20
Beyond Air, Inc. (XAIR) CEO Steve Lisi on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 06/23/20